Related Experiment Video
Updated: Feb 21, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
15.1K
[Lipid-lowering therapy in the elderly]
1Service de Gériatrie du C.H.U. Tivoli, La Louvière.
Revue Medicale De Bruxelles
|October 6, 2017
Summary
Statin therapy benefits elderly individuals by reducing cardiovascular events and improving survival, especially for secondary prevention. For primary prevention, consider statins based on individual risk factors and life expectancy.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Context:
- Increasing life expectancy in Western countries highlights the aging population.
- Cardiovascular diseases remain the primary cause of mortality among the elderly.
- Cardiovascular risk escalates with age, necessitating targeted interventions.
Purpose:
- To evaluate the clinical benefits of statin therapy in the elderly population.
- To provide evidence-based recommendations for statin use in elderly cardiovascular disease prevention.
Summary:
- Clinical studies demonstrate significant benefits of statin therapy for elderly patients, including reduced cardiovascular events and enhanced survival rates.
- Statin therapy is recommended for secondary prevention of cardiovascular disease in older adults.
- For primary prevention, statin use in the elderly should be individualized, considering other risk factors and projected life expectancy.
Impact:
- Statin therapy represents a crucial intervention for managing cardiovascular risk in aging populations.
- Evidence supports the use of statins to improve health outcomes and longevity in the elderly.
- Personalized approaches to statin therapy can optimize cardiovascular health in older adults.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.5K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K
01:15Drug Dosing: Geriatric Patients
308
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
308
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
249
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
249
01:26Atherosclerosis III: Management
473
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
473
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
287
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
287
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
748
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
748